Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (15026)	2/13/1998 6:05:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

Robert Barry, May I ask where you found this information? Thank you, RXGOLF

To: Machaon who wrote (15026)	2/13/1998 7:08:00 PM
From: Henry Niman	Respond to of 32384

bob, I've been mentioning FDA reform and it's effect on Biotechs in general and LGND in particular for some time now and I hope to be able to put up at section on the web site at home.att.net LGND has been putting out so much good news lately and the more in depth posts have kept me busy and I've fallen a bit behind schedule. However, you are correct about the reform helping off label promotion, and for LGND, the timing is just about perfect and they are positioned to be a major benefactor of the new legislation.